New Launch20 May 2026, 04:01 pm

Royal Sense Launches New Pharmaceutical Products

AI Summary

Royal Sense Ltd has announced the launch of new pharmaceutical products, available for sale from May 20, 2026. The product range includes STERGICLAV 625, SMARTYCALV 625, STERPRAX, STERGIPAM MD, STERGICET, STERPIDEM MD, and STERGIC BLOOD PRESSURE MONITOR. The company highlights the features and benefits of STERGICLAV 625 and SMARTYCALV 625, emphasizing their broad-spectrum antibacterial activity and effectiveness against resistant bacteria. The company caters to the domestic market.

Key Highlights

Royal Sense launches seven new pharmaceutical products, targeting the domestic market.
Products include antibiotics, tablets for anxiety/sleep, and a blood pressure monitor.
STERGICLAV 625 and SMARTYCALV 625 are broad-spectrum antibiotics with dual-action formulas.
The anti-infective market in India is estimated at over ₹20,000 Crore.
Amoxicillin + Clavulanate segment has a strong presence in acute infection treatment.

View BSE Filing

ROYAL

Medical Equipment & Supplies

Royal Sense Ltd

Price Impact